Oxaliplatin
OX-03-087
Phase 2 small_molecule active
Quick answer
Oxaliplatin for Previously Treated Metastatic Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Previously Treated Metastatic Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active